Keynote 564 - a flawed study
Listen now
Description
Another flawed study Keynote 564. Pembro in adjuvant RCC
More Episodes
Patient advocates, Pharma funding, and is MRD a suitable endpoint
Published 04/17/24
Published 04/17/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
